Position in LNTH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,315,494
+$3,999,332 QoQ
Shares Held
65,941
+50.8% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#89
of 462 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LNTH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bridgewater Associates, LP holds $207,447,311 across 14 Drug Manufacturers - Specialty & Generic names. LNTH ranks #6 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
111,326 | $60,319,766 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,326,678 | $44,947,850 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
205,677 | $34,664,801 | |
| 4 | VTRS |
Viatris Inc
|
1,698,341 | $26,969,655 | |
| 5 | ZTS |
Zoetis Inc.
|
134,203 | $9,643,827 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
This page
|
65,941 | $7,315,494 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
491,057 | $4,910,570 | |
| 8 | BHC |
Bausch Health Companies Inc.
|
866,285 | $4,270,785 |
All Filings in LNTH
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,315,494 | 65,941 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,316,162 | 43,720 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,094,284 | 166,706 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $15,228,924 | 296,918 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $32,568,164 | 397,852 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $29,587,635 | 303,152 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $9,811,793 | 109,678 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $7,733,204 | 70,462 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $8,762,288 | 109,133 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,753,268 | 76,370 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $4,443,602 | 71,671 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,518,379 | 79,424 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6,150,328 | 73,288 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $6,732,024 | 81,541 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,058,505 | 79,641 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $7,508,149 | 106,756 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $7,044,344 | 106,684 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $5,308,819 | 95,983 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,115,643 | 73,231 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,685,789 | 65,646 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,933,445 | 69,951 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||